229
Views
79
CrossRef citations to date
0
Altmetric
Original Research

Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity

, , &
Pages 4133-4144 | Published online: 13 Jul 2018

References

  • XuDLiYZhangBResveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in ratsInt J Med Sci2016131294295427994500
  • Andrade VolkartPBenedetti GassenRMuhlen NogueiraBNery PortoBEduardo VargasJArigony SoutoAAntitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell lineBioorg Med Chem Lett201727153238324228647350
  • MontesanoALuziLSenesiPMazzocchiNTerruzziIResveratrol promotes myogenesis and hypertrophy in murine myoblastsJ Transl Med20131131024330398
  • PenalvaREsparzaILarranetaEGonzalez-NavarroCJGamazoCIracheJMZein-based nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shockJ Agric Food Chem201563235603561126027429
  • YenCCChangCWHsuMCWuYTSelf-nanoemulsifying drug delivery system for resveratrol: enhanced oral bioavailability and reduced physical fatigue in ratsInt J Mol Sci2017189E185328841149
  • AmriAChaumeilJCSfarSCharrueauCAdministration of resveratrol: What formulation solutions to bioavailability limitations?J Control Release2012158218219321978644
  • WalleTBioavailability of resveratrolAnn N Y Acad Sci2011121591521261636
  • ZhouJZhouMYangFFInvolvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsionsMol Pharm20151241084109525723098
  • FranciosoAMastromarinoPMasciAd’ErmeMMoscaLChemistry, stability and bioavailability of resveratrolMed Chem201410323724524329932
  • Bernkop-SchnurchANanocarrier systems for oral drug delivery: do we really need them?Eur J Pharm Sci201349227227723537503
  • da LuzCMBoylesMSFalagan-LotschPPoly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid raftsJ Nanobiotechnology20171511128143572
  • WangJLiLWuLDevelopment of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: in vitro and in vivo evaluationEur J Pharm Sci20179918519227989702
  • PaulPKNopparatJNuanplubMTreetongASuedeeRImprovement in insulin absorption into gastrointestinal epithelial cells by using molecularly imprinted polymer nanoparticles: microscopic evaluation and ultrastructureInt J Pharm20175301–227929028764982
  • ShahnazGEdagwaBJMcMillanJDevelopment of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasisNanomedicine (Lond)20171229911527879160
  • ZhangXChenGZhangTMaZWuBEffects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigationInt J Nanomedicine201495503551425473287
  • KarasovWHIntegrative physiology of transcellular and paracellular intestinal absorptionJ Exp Biol2017220Pt 142495250128724701
  • CuraAJCarruthersARole of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasisCompr Physiol20122286391422943001
  • MizumaTOhtaKHayashiMAwazuSIntestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugsBiochem Pharmacol1992439203720391596291
  • FachinettiNRigonRBEloyJOSatoMRDos SantosKCChorilliMComparative study of glyceryl behenate or polyoxyethylene 40 stearate-based lipid carriers for trans-resveratrol delivery: development, characterization and evaluation of the in vitro tyrosinase inhibitionAAPS PharmSciTech20181931401140929404955
  • PujaraNJambhrunkarSWongKYMcGuckinMPopatAEnhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolateJ Colloid Interface Sci201748830330827838554
  • JuereEFlorekJBouchouchaMJambhrunkarSWongKYPopatAKleitzFIn vitro dissolution, cellular membrane permeability, and anti-inflammatory response of resveratrol-encapsulated mesoporous silica nanoparticlesMol Pharm201714124431444129094948
  • MohammadiGShakeriAFattahiAMohammadiPMikaeiliAAliabadiAAdibkiaKPreparation, physicochemical characterization and anti-fungal evaluation of nystatin-loaded PLGA-glucosamine nanoparticlesPharm Res201734230130927928646
  • LiWZhangTYeYZhangXWuBEnhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier materialInt J Pharm2015495294895526453780
  • NozawaTImaiTPrediction of human intestinal absorption of the prodrug temocapril by in situ single-pass perfusion using rat intestine with modified hydrolase activityDrug Metab Dispos20113971263126921474683
  • DengWXieQWangHMaZWuBZhangXSelenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanismNanomedicine20171361965197428539272
  • RuanBFGeWWChengHJXuHJLiQSLiuXHResveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activityJ Enzyme Inhib Med Chem20173211282129029072109
  • ZhangXWangHZhangTZhouXWuBExploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drugEur J Pharm Sci20146230130824956461
  • BalzusBSahleFFHonzkeSFormulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epitheliumEur J Pharm Biopharm201711512213028189623
  • ChenZTaiZGuFHuCZhuQGaoSAptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacyEur J Pharm Biopharm201610713014127393562
  • MarierJFVachonPGritsasAZhangJMoreauJPDucharmeMPMetabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat modelJ Pharmacol Exp Ther2002302136937312065739
  • PachaJDevelopment of intestinal transport function in mammalsPhysiol Rev20008041633166711015621
  • LehmannAHornbyPJIntestinal SGLT1 in metabolic health and diseaseAm J Physiol Gastrointest Liver Physiol201631011G887G89827012770
  • ZhangJTangCYinCGalactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophagesBiomaterials201334143667367723419643
  • JainAKesharwaniPGargNKGalactose engineered solid lipid nanoparticles for targeted delivery of doxorubicinColloids Surf B Biointerfaces2015134475826142628
  • KuhnleGSpencerJPChowrimootooGResveratrol is absorbed in the small intestine as resveratrol glucuronideBiochem Biophys Res Commun2000272121221710872829
  • SelviRBChatterjeeSJagadeesanDChaturbedyPSumaBSEswaramoorthyMKunduTKATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptorsJ Nanobiotechnology2012103522857258
  • JainAJainAParajuliPRecent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugsDrug Discov Today Epub2017111010.1016/j.drudis.2017.11.003
  • MatsudaYMinagawaTOkuiTYamazakiKResveratrol suppresses the alveolar bone resorption induced by artificial trauma from occlusion in miceOral Dis201824341242128944599
  • XiangFFHeJWLiuZXPengQZWeiHTwo new guaiane-type sesquiterpenes from Curcuma kwangsiensis and their inhibitory activity of nitric oxide production in lipopolysaccharide-stimulated macrophages. Nat Prod ResEpub20179201610.1080/14786419.2017.1378203
  • FeiMBhatiaSOrissTBTNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infectionProc Natl Acad Sci U S A2011108135360536521402950
  • ZhangHChenWInterleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitisExp Ther Med20171432271227628962154
  • SharmaJNAl-OmranAParvathySSRole of nitric oxide in inflammatory diseasesInflammopharmacology200715625225918236016